Skip to main content

Table 1 Characteristics of sepsis patients and hospital controls

From: Neutrophils with myeloid derived suppressor function deplete arginine and constrain T cell function in septic shock patients

 

Sepsis with shock

Sepsis no shock

Hospital controls

Sepsis shock versus no shock

All sepsis versus control

Subjects, n

12

12

12

  

Age, years

52 (45 to 57)

45 (39 to 55)

49 (40 to 56)

ns

ns

Male, n (%)

7 (58%)

6 (50%)

8 (67%)

ns

ns

ATSI, n (%)

10 (83%)

7 (58%)

8 (67%)

ns

ns

APACHE II score, day 0

20 (29 to 23)

8 (4 to 14)

 

<0.0001

N/A

SOFA score, day 0

10 (4 to 10)

1 (0 to 2)

 

<0.0001

N/A

Plasma L-arginine, μM

39 (25 to 53)

40 (21 to 48)

74 (65 to 88)

ns

<0.0001

Plasma IL-6, pg/mL

1433 (400 to 4290)

82 (42 to 302)

5 (5 to 5)

<0.0001

<0.0001

Plasma IL-10 (pg/mL), median (range)

65 (5 to 9525)

5 (5 to 72)

5 (5)

0.001

0.004

Plasma VEGF, pg/mL

89 (16 to 115)

79 (62 to 138)

51 (32 to 71)

ns

0.03

Plasma arginase, μmol/mL/hr

0.18 (0.1 to 0.23)*

0.19 (0.12 to 0.26)

0.14 (0.09 to 0.16)

ns

ns

Interphase-neutrophils (%)

19.2 (4.4 to 29.5)

2.7 (1.5 to 6.1)

1.5 (0 to 2.0)

0.02

0.001

Neutrophil × 103/μL

13.1 (7.2 to 19.4)

14.2 (11.4 to 16.6)

6 (4.0 to 9.6)

ns

0.02

Imm. granulocyte × 103/μL, median (range)

0.4 (0 to 11.8)

0 (0 to 7.6)

0 (0 to 0)

0.05

N/A

Monocyte × 103/μL

0.45 (0.1 to 1.2)

0.65 (0.4 to 1)

0.55 (0.5 to 0.7)

ns

ns

Lymphocyte × 103/μL

1.2 (0.5 to 2.1)

1.2 (0.8 to 1.6)

2.2 (1.5 to 2.4)

ns

ns

Causative organism, n (%)

     

None cultured

5 (42%)

9 (75%)

   

Gram-positive bacteria

4 (33%)

2 (17%)

   

Gram-negative bacteria

3 (25%)

1 (8%)

   
  1. Values show the median (interquartile range) unless stated otherwise. *n = 11, Interphase neutrophil (%) indicates the proportion of neutrophils in the total interphase layer (gated per Figure 1A). ATSI, Aboriginal or Torres Strait Islander; APACHE, acute physiology and chronic health evaluation; SOFA, sequential organ failure assessment; VEGF, vascular endothelial growth factor; N/A, not assessed; ns, not significant.